Estimating the world cancer burden: Globocan 2000
By D. M. Parkin, F. Bray, J. Ferlay, P. Pisani. International Journal of Cancer, 2001
3,992 citations recorded by the source corpus.
Subfields: Economics and Econometrics, Oncology
View Paper: https://www.semanticscholar.org/paper/5b9e7852b702d4f11d4b090359c5e72f017e1e68
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Urothelial tumorigenesis: a tale of divergent pathways (2005, background): “gov/cancertopics/types/bladder">urothelial carcinoma is one of the most common cancers — it ranks fifth among all cancers in the Western world, and there are 336,000 new cases and 132,000 deaths annually worldwid”
- Epidemiology of pancreatic cancer: an overview (2009, background): “At the beginning of the 21 st century, the estimated number of pancreatic cancers throughout the world was 110,000, with an estimated global mortality rate of 98%”
- Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. (2006, background): “While Rnf19 has not been linked to tumorigenesis, c-myc alterations are common in human liver cancer (Peng et al., 1993), and myc cooperates with oncogenic Ras in transgenic models of HCC (Sandgren et al., 1989).”
- Drug discovery from medicinal plants. (2005, background): “Since 1990 there has been a 22% increase in cancer incidence and mortality with the four most frequent cancers being lung, breast, colorectal, and stomach and the four most deadly cancers being lung, stomach, liver, and colorectal (Parkin et al., 2001).”